Oral immunization with a live coxsackievirus/HIV recombinant induces gag p24-specific T cell responses.
The development of an HIV/AIDS vaccine has proven to be elusive. Because human vaccine trials have not yet demonstrated efficacy, new vaccine strategies are needed for the HIV vaccine pipeline. We have been developing a new HIV vaccine platform using a live enterovirus, coxsackievirus B4 (CVB4) vect...
Main Authors: | Rui Gu, Anae Shampang, Toufic Nashar, Manisha Patil, Deborah H Fuller, Arlene I Ramsingh |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-09-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2932689?pdf=render |
Similar Items
-
Phylodynamic analysis of Coxsackievirus CA24v
by: Jing-Yun Zeng, et al.
Published: (2014) -
Phylodynamic Characterization of an Ocular-Tropism Coxsackievirus A24 Variant.
by: Yung-Chang Yen, et al.
Published: (2016-01-01) -
Recombinant Coxsackievirus A2 and Deaths of Children, Hong Kong, 2012
by: Cyril C.Y. Yip, et al.
Published: (2013-08-01) -
Generation of a recombinant Gag virus-like-particle panel for the evaluation of p24 antigen detection by diagnostic HIV tests.
by: Beatrice N Vetter, et al.
Published: (2014-01-01) -
New Insights into HTLV-1 Particle Structure, Assembly, and Gag-Gag Interactions in Living Cells
by: Jolene L. Johnson, et al.
Published: (2011-06-01)